Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients Biotech Investing
Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC Biotech Investing
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America Biotech Investing
Theratechnologies Announces Availability of EGRIFTA WR for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy Biotech Investing
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference Biotech Investing
